Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.

Abstract

AIMS To determine the cost-effectiveness of long-acting injectable (LAI) antipsychotics for chronic schizophrenia in Sweden. METHODS A 1-year decision tree was developed for Sweden using published data and expert opinion. Five treatment strategies lasting 1 year were compared: paliperidone palmitate (PP-LAI), olanzapine pamoate (OLZ-LAI), risperidone (RIS… (More)
DOI: 10.3109/08039488.2013.852243

Topics

Cite this paper

@article{Einarson2014PharmacoeconomicsOD, title={Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.}, author={Thomas R Einarson and Colin Vicente and Roman Zilbershtein and Charles Piwko and Christel N B\o and Hanna Pudas and Rasmus Jensen and Michiel E H Hemels}, journal={Nordic journal of psychiatry}, year={2014}, volume={68 6}, pages={416-27} }